Thanks for the explanation and the subsequent posters for clarification
You can have the best drug in the world, but without a good management team it will go nowhere. The chairman of Imugene said something along those lines
It is certainly a big couple of months ahead and the need for improvement in communications is paramount. Maybe Scott needs to do another podcast with PR. The last one was informative. I seem to remember him saying they are looking for a new Chair. Maybe PR will remain CEO
Sass, page-44
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |